Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
about
A new standard of care for the management of peritoneal surface malignancyExtensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival.Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential - A Comparison of Two Cases.Pseudomyxoma peritonei.Pseudomyxoma peritonei of 92 Chinese patients: clinical characteristics, pathological classification and prognostic factors.Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin.Clinicopathological features and prognosis of pseudomyxoma peritonei.Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.Postoperative peritonitis without an underlying digestive fistula after complete cytoreductive surgery plus HIPEC.The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry.Clinical presentation of pseudomyxoma peritonei.Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.A new policy regarding ovarian resection in young women treated for peritoneal carcinomatosis.Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors.Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.Does obesity affect outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for disseminated mucinous appendiceal neoplasms?Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei.Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer.Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy.HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy.Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia.Does having a gastrectomy delay time to feeding and prolong hospital stay in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei.Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.Histologic and Immunohistochemical Alterations Associated with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy.Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei
P2860
Q24626790-1EB59415-4EF0-4065-9E19-C6AC49350F52Q33909347-26267F95-019A-4817-89DB-B6D389A8A088Q34054735-246160AC-A188-44B0-A583-5DBDE13AF67AQ34391046-DECEB207-F2E1-40C6-9237-7766962801B6Q36066815-A837A7DC-3597-42E6-A0BE-00DC0FE11B32Q36611761-C8079980-E4B1-4BC9-8D49-37698E7BF476Q37267412-CEA729E4-50C6-4E78-8472-54BFF2F0DADCQ37388412-18C8AD1B-C8B0-466E-9B36-A011CE8767F2Q37512841-A5614C40-38DB-418C-949E-6FFB174A2277Q37645734-F75AD358-039C-445D-AE6C-CCBCCCC699CAQ37650823-A68C2D79-2A3A-4370-8088-06EF4798525CQ37821133-8B19FD53-F210-49B6-9F79-DD2512A36008Q37993908-6C67728D-6DA8-46DF-94BB-FAEFEF675878Q38244051-D1272DEA-9DC2-4DFE-A374-FE94F2537929Q39474649-83CB159B-7287-48F0-999E-C5E7A94D1698Q39659175-5BCC3C9A-29D7-40C8-B09E-E1667FF1D479Q39964992-E69B1A6E-BD46-44C9-AB81-9766212F0A32Q40474762-4C8E7EC2-D6E8-4C4D-937B-426AEF774BA8Q43463915-B87C9CC8-84C7-4F29-A68F-7FD55C9ABDF5Q44233641-FB0D80C0-E3A3-4B01-9827-3EB43EE538DDQ44646347-B95CCF28-2687-4496-AA1F-F6C47D4E6E26Q46643571-2C1E9B66-D859-4605-BA2A-C9D64CAE495AQ46656530-B19EEE83-7014-46EB-BDFE-1CFCC1DF18BEQ48552231-BF5EE038-C419-4358-988A-D201AF19B8B8Q50076428-3B2FE246-7A09-44FB-9313-DFAC56BF3C8BQ50540275-77667258-DA29-4C89-876E-0A694B8172ADQ50558486-BAD77FEA-30EF-47AB-A104-E132E54A5B60Q50951335-B4A9682E-13FD-4FD1-A599-7888BE5AB15DQ52974714-24C9C819-3D33-4941-BB13-EA06D72808E0Q53516654-605D1A35-358A-416B-B75F-AC815AAF639DQ57121135-B9BB450D-EB7A-4291-8026-FFFA5AEE2847
P2860
Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Peritoneal pseudomyxoma: resul ...... intraperitoneal chemotherapy.
@ast
Peritoneal pseudomyxoma: resul ...... intraperitoneal chemotherapy.
@en
Peritoneal pseudomyxoma: resul ...... intraperitoneal chemotherapy.
@nl
type
label
Peritoneal pseudomyxoma: resul ...... intraperitoneal chemotherapy.
@ast
Peritoneal pseudomyxoma: resul ...... intraperitoneal chemotherapy.
@en
Peritoneal pseudomyxoma: resul ...... intraperitoneal chemotherapy.
@nl
prefLabel
Peritoneal pseudomyxoma: resul ...... intraperitoneal chemotherapy.
@ast
Peritoneal pseudomyxoma: resul ...... intraperitoneal chemotherapy.
@en
Peritoneal pseudomyxoma: resul ...... intraperitoneal chemotherapy.
@nl
P2093
P356
P1476
Peritoneal pseudomyxoma: resul ...... intraperitoneal chemotherapy.
@en
P2093
P Duvillard
R Ciuchendéa
P2860
P304
P356
10.1002/BJS.6235
P407
P50
P577
2008-09-01T00:00:00Z